Jay D. Kranzler, CEO at CYPRESS BIOSCIENCE INC (CYPB), sold 5,000 shares at $8.10 ($40K) on 2007-03-26, disclosed to the SEC on 2007-03-28.
Scheduled sale ($40k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.93 | 300 | $2K | 5.9% |
| 2 | $7.95 | 100 | $795 | 2.0% |
| 3 | $7.98 | 100 | $798 | 2.0% |
| 4 | $7.99 | 400 | $3K | 7.9% |
| 5 | $8.00 | 200 | $2K | 4.0% |
| 6 | $8.01 | 833 |
| $7K |
| 16.6% |
| 7 | $8.02 | 200 | $2K | 4.0% |
| 8 | $8.03 | 800 | $6K | 16.0% |
| 9 | $8.04 | 600 | $5K | 12.0% |
| 10 | $8.05 | 35 | $282 | 0.7% |
| 11 | $8.06 | 65 | $524 | 1.3% |
| 12 | $8.09 | 200 | $2K | 4.0% |
| 13 | $8.10 | 467 | $4K | 9.4% |
| 14 | $8.14 | 100 | $814 | 2.0% |
| 15 | $8.18 | 100 | $818 | 2.0% |
| 16 | $8.22 | 200 | $2K | 4.1% |
| 17 | $8.24 | 100 | $824 | 2.0% |
| 18 | $8.25 | 100 | $825 | 2.0% |
| 19 | $8.26 | 100 | $826 | 2.1% |
| Total | $8.05 avg | 5,000 | $40K | 100% |
| Filing → |
| CYPB | SELL | 2010-12-29 | $162K | — | Filing → |
| CYPB | SELL | 2010-12-29 | $983K | — | Filing → |
| CYPB | SELL | 2009-08-04 | $652K | — | Filing → |